These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10397254

  • 1. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
    Helfand SC, Dickerson EB, Munson KL, Padilla ML.
    Cancer Res; 1999 Jul 01; 59(13):3119-27. PubMed ID: 10397254
    [Abstract] [Full Text] [Related]

  • 2. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC, Hank JA, Gan J, Sondel PM.
    Cell Immunol; 1996 Jan 10; 167(1):99-107. PubMed ID: 8548851
    [Abstract] [Full Text] [Related]

  • 3. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
    Boussiotis VA, Pardo NA, Collins H, Houghton A, Ritz J, Nadler LM, Soiffer RJ.
    Eur J Immunol; 1996 Sep 10; 26(9):2149-54. PubMed ID: 8814260
    [Abstract] [Full Text] [Related]

  • 4. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
    Chapman PB, Lonberg M, Houghton AN.
    Cancer Res; 1990 Mar 01; 50(5):1503-9. PubMed ID: 2105840
    [Abstract] [Full Text] [Related]

  • 5. Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3).
    Norihisa Y, McVicar DW, Ghosh P, Houghton AN, Longo DL, Creekmore SP, Blake T, Ortaldo JR, Young HA.
    J Immunol; 1994 Jan 15; 152(2):485-95. PubMed ID: 8283032
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
    Reaman GH, Taylor BJ, Merritt WD.
    Cancer Res; 1990 Jan 01; 50(1):202-5. PubMed ID: 2403416
    [Abstract] [Full Text] [Related]

  • 9. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W, Shau H, Hadley CG, Morgan AC, Reisfeld RA, Cheresh DA, Mitchell MS.
    Cancer Res; 1990 Oct 01; 50(19):6311-5. PubMed ID: 2400994
    [Abstract] [Full Text] [Related]

  • 10. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.
    Chapman PB, Yuasa H, Houghton AN.
    J Immunol; 1990 Aug 01; 145(3):891-8. PubMed ID: 1695649
    [Abstract] [Full Text] [Related]

  • 11. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.
    Ramos AS, Parise CB, Travassos LR, Han SW, de Campos-Lima PO, de Moraes JZ.
    Cancer Sci; 2011 Jan 01; 102(1):64-70. PubMed ID: 21070480
    [Abstract] [Full Text] [Related]

  • 12. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.
    Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM.
    J Immunother Emphasis Tumor Immunol; 1994 Oct 01; 16(3):188-97. PubMed ID: 7834118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin.
    Iglesias-Bartolomé R, Crespo PM, Gomez GA, Daniotti JL.
    FEBS J; 2006 Apr 01; 273(8):1744-58. PubMed ID: 16623710
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies.
    Merritt WD, Sztein MB, Taylor B, Reaman GH.
    Leukemia; 1991 Dec 01; 5(12):1087-91. PubMed ID: 1774957
    [Abstract] [Full Text] [Related]

  • 16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 01; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 18. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.
    Bajorin DF, Chapman PB, Wong G, Coit DG, Kunicka J, Dimaggio J, Cordon-Cardo C, Urmacher C, Dantes L, Templeton MA.
    Cancer Res; 1990 Dec 01; 50(23):7490-5. PubMed ID: 2253196
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells.
    Claus C, Schlaak J, Dittmayer M, Meyer zum Büschenfelde K, Dippold W.
    Eur J Immunol; 1994 May 01; 24(5):1208-12. PubMed ID: 8181530
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.